{"id":"https://openalex.org/W2931635538","doi":"https://doi.org/10.1016/j.ygyno.2019.03.250","title":"The efficacy and safety of Tipapkinogen Sovacivec therapeutic HPV vaccine in cervical intraepithelial neoplasia grades 2 and 3: Randomized controlled phase II trial with 2.5 years of follow-up","display_name":"The efficacy and safety of Tipapkinogen Sovacivec therapeutic HPV vaccine in cervical intraepithelial neoplasia grades 2 and 3: Randomized controlled phase II trial with 2.5 years of follow-up","publication_year":2019,"publication_date":"2019-04-04","ids":{"openalex":"https://openalex.org/W2931635538","doi":"https://doi.org/10.1016/j.ygyno.2019.03.250","mag":"2931635538","pmid":"https://pubmed.ncbi.nlm.nih.gov/30955915"},"language":"en","primary_location":{"id":"doi:10.1016/j.ygyno.2019.03.250","doi":"https://doi.org/10.1016/j.ygyno.2019.03.250","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ygyno.2019.03.250","pdf_url":"http://www.gynecologiconcology-online.net/article/S0090825819304846/pdf","source":{"id":"https://openalex.org/S2574783","display_name":"Gynecologic Oncology","issn_l":"0090-8258","issn":["0090-8258","1095-6859"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gynecologic Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.gynecologiconcology-online.net/article/S0090825819304846/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074359918","display_name":"Diane  Medved Harper","orcid":"https://orcid.org/0000-0001-7648-883X","observed_orcids":["https://orcid.org/0000-0001-7648-883X"]},"institutions":[{"id":"https://openalex.org/I75421653","display_name":"University of Missouri\u2013Kansas City","ror":"https://ror.org/01w0d5g70","country_code":"US","type":"education","lineage":["https://openalex.org/I75421653"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Diane M. Harper","raw_affiliation_strings":["Department of Family and Community Medicine, Obstetrics and Gynecology, University of Missouri Kansas City, 7900 Lee's Summit Road, Kansas City, MO 64139, USA. Electronic address: harperdi@med.umich.edu","Department of Family and Community Medicine, Obstetrics and Gynecology, University of Missouri Kansas City, 7900 Lee's Summit Road, Kansas City, MO 64139, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Family and Community Medicine, Obstetrics and Gynecology, University of Missouri Kansas City, 7900 Lee's Summit Road, Kansas City, MO 64139, USA. Electronic address: harperdi@med.umich.edu","institution_ids":["https://openalex.org/I75421653"]},{"raw_affiliation_string":"Department of Family and Community Medicine, Obstetrics and Gynecology, University of Missouri Kansas City, 7900 Lee's Summit Road, Kansas City, MO 64139, USA","institution_ids":["https://openalex.org/I75421653"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085063339","display_name":"Pekka Nieminen","orcid":"https://orcid.org/0000-0001-5671-8685","observed_orcids":["https://orcid.org/0000-0001-5671-8685"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]},{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI"],"is_corresponding":true,"raw_author_name":"Pekka Nieminen","raw_affiliation_strings":["Department of Obstetrics and Gynaecology, Helsinki University Hospital and Helsinki University, Box 615, 00029 HUS, Helsinki, Finland. Electronic address: pekka.nieminen@hus.fi","Department of Obstetrics and Gynaecology, Helsinki University Hospital and Helsinki University, Box 615, 00029 HUS, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynaecology, Helsinki University Hospital and Helsinki University, Box 615, 00029 HUS, Helsinki, Finland. Electronic address: pekka.nieminen@hus.fi","institution_ids":["https://openalex.org/I133731052","https://openalex.org/I2800394112"]},{"raw_affiliation_string":"Department of Obstetrics and Gynaecology, Helsinki University Hospital and Helsinki University, Box 615, 00029 HUS, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052","https://openalex.org/I2800394112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003323285","display_name":"Gilbert G.G. Donders","orcid":"https://orcid.org/0000-0001-9890-6254","observed_orcids":["https://orcid.org/0000-0001-9890-6254"]},"institutions":[{"id":"https://openalex.org/I4210102047","display_name":"Antwerp University Hospital","ror":"https://ror.org/01hwamj44","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210102047"]}],"countries":["BE"],"is_corresponding":true,"raw_author_name":"Gilbert Donders","raw_affiliation_strings":["Department of Obstetrics and Gynaecology, University Hospital Antwerp, Wilrijksesteenweg 10, 2000 Antwerp-Ekeren, Belgium. Electronic address: Gilbert.Donders@uza.be","Department of Obstetrics and Gynaecology, University Hospital Antwerp, Wilrijksesteenweg 10, 2000 Antwerp-Ekeren, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynaecology, University Hospital Antwerp, Wilrijksesteenweg 10, 2000 Antwerp-Ekeren, Belgium. Electronic address: Gilbert.Donders@uza.be","institution_ids":["https://openalex.org/I4210102047"]},{"raw_affiliation_string":"Department of Obstetrics and Gynaecology, University Hospital Antwerp, Wilrijksesteenweg 10, 2000 Antwerp-Ekeren, Belgium","institution_ids":["https://openalex.org/I4210102047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024186639","display_name":"Mark H. Einstein","orcid":"https://orcid.org/0000-0001-7422-0338","observed_orcids":["https://orcid.org/0000-0001-7422-0338"]},"institutions":[{"id":"https://openalex.org/I129975664","display_name":"Albert Einstein College of Medicine","ror":"https://ror.org/05cf8a891","country_code":"US","type":"education","lineage":["https://openalex.org/I129975664","https://openalex.org/I4210112371"]},{"id":"https://openalex.org/I1335289525","display_name":"Montefiore Medical Center","ror":"https://ror.org/044ntvm43","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1335289525","https://openalex.org/I19772626"]},{"id":"https://openalex.org/I4390039242","display_name":"Montefiore Einstein Comprehensive Cancer Center","ror":"https://ror.org/00cea8r21","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I129975664","https://openalex.org/I4210112371","https://openalex.org/I4390039242"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mark H. Einstein","raw_affiliation_strings":["Department of Obstetrics and Gynecology, Albert Einstein Cancer Center and Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467, USA. Electronic address: me399@njms.rutgers.edu","Department of Obstetrics and Gynecology, Albert Einstein Cancer Center and Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynecology, Albert Einstein Cancer Center and Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467, USA. Electronic address: me399@njms.rutgers.edu","institution_ids":["https://openalex.org/I129975664","https://openalex.org/I1335289525","https://openalex.org/I4390039242"]},{"raw_affiliation_string":"Department of Obstetrics and Gynecology, Albert Einstein Cancer Center and Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467, USA","institution_ids":["https://openalex.org/I129975664","https://openalex.org/I1335289525","https://openalex.org/I4390039242"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074215084","display_name":"Francisco Garc\u00eda","orcid":"https://orcid.org/0000-0002-9195-6627","observed_orcids":["https://orcid.org/0000-0002-9195-6627"]},"institutions":[{"id":"https://openalex.org/I138006243","display_name":"University of Arizona","ror":"https://ror.org/03m2x1q45","country_code":"US","type":"education","lineage":["https://openalex.org/I138006243"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Francisco Garcia","raw_affiliation_strings":["Center of Excellence in Women's Health at the University of Arizona, 1501 N Campbell Ave, Tucson, AZ 85714, USA. Electronic address: Francisco.Garcia@pima.gov","Center of Excellence in Women's Health at the University of Arizona, 1501 N Campbell Ave, Tucson, AZ 85714, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center of Excellence in Women's Health at the University of Arizona, 1501 N Campbell Ave, Tucson, AZ 85714, USA. Electronic address: Francisco.Garcia@pima.gov","institution_ids":["https://openalex.org/I138006243"]},{"raw_affiliation_string":"Center of Excellence in Women's Health at the University of Arizona, 1501 N Campbell Ave, Tucson, AZ 85714, USA","institution_ids":["https://openalex.org/I138006243"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076400654","display_name":"Warner King Huh","orcid":"https://orcid.org/0000-0003-2881-9846","observed_orcids":["https://orcid.org/0000-0003-2881-9846"]},"institutions":[{"id":"https://openalex.org/I17301866","display_name":"University of Alabama","ror":"https://ror.org/03xrrjk67","country_code":"US","type":"education","lineage":["https://openalex.org/I17301866"]},{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Warner K. Huh","raw_affiliation_strings":["Department of Obstetrics and Gynecology, University of Alabama, 1700 6th Avenue South, WIC Room 10250, Birmingham, AL 35233, USA. Electronic address: whuh@uabmc.edu","Department of Obstetrics and Gynecology, University of Alabama, 1700 6th Avenue South, WIC Room 10250, Birmingham, AL 35233, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynecology, University of Alabama, 1700 6th Avenue South, WIC Room 10250, Birmingham, AL 35233, USA. Electronic address: whuh@uabmc.edu","institution_ids":["https://openalex.org/I17301866","https://openalex.org/I32389192"]},{"raw_affiliation_string":"Department of Obstetrics and Gynecology, University of Alabama, 1700 6th Avenue South, WIC Room 10250, Birmingham, AL 35233, USA","institution_ids":["https://openalex.org/I17301866","https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058641567","display_name":"Mark H. Stoler","orcid":"https://orcid.org/0000-0002-2784-1008","observed_orcids":["https://orcid.org/0000-0002-2784-1008"]},"institutions":[{"id":"https://openalex.org/I2799765794","display_name":"University of Virginia Health System","ror":"https://ror.org/00wn7d965","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799765794"]},{"id":"https://openalex.org/I4210134211","display_name":"University of Virginia Medical Center","ror":"https://ror.org/046kb4y45","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799765794","https://openalex.org/I4210134211"]},{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mark H. Stoler","raw_affiliation_strings":["Surgical Pathology, P.O. Box 800214, Department of Pathology, University of Virginia Health System, University of Virginia, Charlottesville, VA, USA. Electronic address: mhs2e@me.comall","Surgical Pathology, P.O. Box 800214, Department of Pathology, University of Virginia Health System, University of Virginia, Charlottesville, VA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Surgical Pathology, P.O. Box 800214, Department of Pathology, University of Virginia Health System, University of Virginia, Charlottesville, VA, USA. Electronic address: mhs2e@me.comall","institution_ids":["https://openalex.org/I2799765794","https://openalex.org/I4210134211","https://openalex.org/I51556381"]},{"raw_affiliation_string":"Surgical Pathology, P.O. Box 800214, Department of Pathology, University of Virginia Health System, University of Virginia, Charlottesville, VA, USA","institution_ids":["https://openalex.org/I2799765794","https://openalex.org/I51556381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055320874","display_name":"Katerina Glavini","orcid":"https://orcid.org/0000-0001-6789-8781","observed_orcids":["https://orcid.org/0000-0001-6789-8781"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"Katerina Glavini","raw_affiliation_strings":["Roche Pharmaceutical Research & Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd. Building 93, Room 7.38.01, Grenzacherstrasse 124, Basel 4070, Switzerland. Electronic address: katerina.glavini@roche.com","Roche Pharmaceutical Research & Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd. Building 93, Room 7.38.01, Grenzacherstrasse 124, Basel 4070, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Pharmaceutical Research & Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd. Building 93, Room 7.38.01, Grenzacherstrasse 124, Basel 4070, Switzerland. Electronic address: katerina.glavini@roche.com","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Roche Pharmaceutical Research & Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd. Building 93, Room 7.38.01, Grenzacherstrasse 124, Basel 4070, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024946615","display_name":"Gemma Attley","orcid":"https://orcid.org/0009-0000-3382-6747","observed_orcids":["https://orcid.org/0009-0000-3382-6747"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Gemma Attley","raw_affiliation_strings":["Roche Pharmaceutical Research & Early Development, Roche Innovation Center New York, 430 E. 29th Street New York City, New York 10016, USA. Electronic address: gemma.attley.ga1@roche.com","Roche Pharmaceutical Research & Early Development, Roche Innovation Center New York, 430 E. 29th Street New York City, New York 10016, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Pharmaceutical Research & Early Development, Roche Innovation Center New York, 430 E. 29th Street New York City, New York 10016, USA. Electronic address: gemma.attley.ga1@roche.com","institution_ids":[]},{"raw_affiliation_string":"Roche Pharmaceutical Research & Early Development, Roche Innovation Center New York, 430 E. 29th Street New York City, New York 10016, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000442708","display_name":"Jean\u2010Marc Limacher","orcid":"https://orcid.org/0000-0002-7723-5508","observed_orcids":["https://orcid.org/0000-0002-7723-5508"]},"institutions":[{"id":"https://openalex.org/I152238723","display_name":"Transgene (France)","ror":"https://ror.org/02d4qpq05","country_code":"FR","type":"company","lineage":["https://openalex.org/I152238723"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Jean-Marc Limacher","raw_affiliation_strings":["Department of Medical Affairs, Transgene SA, 400 Bb Gonthier d'Andernach Parc d'innovation, CS80166, 67405 Illkirch-Graffenstaden Cedex, France. Electronic address: jean-marc.limacher@ch-colmar.fr","Department of Medical Affairs, Transgene SA, 400 Bb Gonthier d'Andernach Parc d'innovation, CS80166, 67405 Illkirch-Graffenstaden Cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Affairs, Transgene SA, 400 Bb Gonthier d'Andernach Parc d'innovation, CS80166, 67405 Illkirch-Graffenstaden Cedex, France. Electronic address: jean-marc.limacher@ch-colmar.fr","institution_ids":["https://openalex.org/I152238723"]},{"raw_affiliation_string":"Department of Medical Affairs, Transgene SA, 400 Bb Gonthier d'Andernach Parc d'innovation, CS80166, 67405 Illkirch-Graffenstaden Cedex, France","institution_ids":["https://openalex.org/I152238723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089022163","display_name":"B\u00e9rang\u00e8re Bastien","orcid":"https://orcid.org/0000-0002-4057-8689","observed_orcids":["https://orcid.org/0000-0002-4057-8689"]},"institutions":[{"id":"https://openalex.org/I152238723","display_name":"Transgene (France)","ror":"https://ror.org/02d4qpq05","country_code":"FR","type":"company","lineage":["https://openalex.org/I152238723"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Berangere Bastien","raw_affiliation_strings":["Department of Biostatistics, Transgene S.A., Boulevard Gonthier d'Andernach Parc d'innovation, CS80166, 67405 Illkirch-Graffenstaden Cedex, France. Electronic address: bastien@transgene.fr","Department of Biostatistics, Transgene S.A., Boulevard Gonthier d'Andernach Parc d'innovation, CS80166, 67405 Illkirch-Graffenstaden Cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, Transgene S.A., Boulevard Gonthier d'Andernach Parc d'innovation, CS80166, 67405 Illkirch-Graffenstaden Cedex, France. Electronic address: bastien@transgene.fr","institution_ids":["https://openalex.org/I152238723"]},{"raw_affiliation_string":"Department of Biostatistics, Transgene S.A., Boulevard Gonthier d'Andernach Parc d'innovation, CS80166, 67405 Illkirch-Graffenstaden Cedex, France","institution_ids":["https://openalex.org/I152238723"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5114223432","display_name":"Elizabeth Calleja","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Elizabeth Calleja","raw_affiliation_strings":["Roche Pharmaceutical Research & Early Development, Roche Innovation Center New York, 430 E. 29th Street New York City, New York 10016, USA. Electronic address: elizabethcalleja@netscape.net","Roche Pharmaceutical Research & Early Development, Roche Innovation Center New York, 430 E. 29th Street New York City, New York 10016, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Pharmaceutical Research & Early Development, Roche Innovation Center New York, 430 E. 29th Street New York City, New York 10016, USA. Electronic address: elizabethcalleja@netscape.net","institution_ids":[]},{"raw_affiliation_string":"Roche Pharmaceutical Research & Early Development, Roche Innovation Center New York, 430 E. 29th Street New York City, New York 10016, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":15,"corresponding_author_ids":["https://openalex.org/A5000442708","https://openalex.org/A5003323285","https://openalex.org/A5024186639","https://openalex.org/A5024946615","https://openalex.org/A5055320874","https://openalex.org/A5058641567","https://openalex.org/A5074215084","https://openalex.org/A5074359918","https://openalex.org/A5076400654","https://openalex.org/A5085063339","https://openalex.org/A5089022163","https://openalex.org/A5114223432"],"corresponding_institution_ids":["https://openalex.org/I118019719","https://openalex.org/I129975664","https://openalex.org/I1335289525","https://openalex.org/I133731052","https://openalex.org/I138006243","https://openalex.org/I152238723","https://openalex.org/I17301866","https://openalex.org/I2799765794","https://openalex.org/I2800394112","https://openalex.org/I32389192","https://openalex.org/I4210102047","https://openalex.org/I4210134211","https://openalex.org/I4390039242","https://openalex.org/I51556381","https://openalex.org/I75421653"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":5.7342,"has_fulltext":true,"cited_by_count":72,"citation_normalized_percentile":{"value":0.96890775,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"153","issue":"3","first_page":"521","last_page":"529"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10146","display_name":"Cervical Cancer and HPV Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10146","display_name":"Cervical Cancer and HPV Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10428","display_name":"Reproductive tract infections research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/therapeutic-hpv-vaccine","display_name":"therapeutic HPV vaccine","score":0.9359999895095825},{"id":"https://openalex.org/keywords/cervical-intraepithelial-neoplasia","display_name":"cervical intraepithelial neoplasia","score":0.9539999961853027},{"id":"https://openalex.org/keywords/cin2-3","display_name":"CIN2/3","score":0.8209999799728394},{"id":"https://openalex.org/keywords/high-risk-hpv","display_name":"high-risk HPV","score":0.8019999861717224},{"id":"https://openalex.org/keywords/vaccine-safety","display_name":"vaccine safety","score":0.7120000123977661},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.5440000295639038}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9405655264854431},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.8088325262069702},{"id":"https://openalex.org/C2777343196","wikidata":"https://www.wikidata.org/wiki/Q196788","display_name":"Cervical intraepithelial neoplasia","level":4,"score":0.7327965497970581},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6311801075935364},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.61126708984375},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6021394729614258},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5661607384681702},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4740828275680542},{"id":"https://openalex.org/C2778580637","wikidata":"https://www.wikidata.org/wiki/Q184627","display_name":"HPV infection","level":4,"score":0.47118404507637024},{"id":"https://openalex.org/C2780441014","wikidata":"https://www.wikidata.org/wiki/Q7907952","display_name":"Vaccine efficacy","level":3,"score":0.4569109380245209},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.45543205738067627},{"id":"https://openalex.org/C2778220009","wikidata":"https://www.wikidata.org/wiki/Q160105","display_name":"Cervical cancer","level":3,"score":0.37412235140800476},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.34068459272384644},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.20151257514953613},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.15412715077400208},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.11376401782035828},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000075662","descriptor_name":"Injection Site Reaction","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002578","descriptor_name":"Uterine Cervical Dysplasia","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002578","descriptor_name":"Uterine Cervical Dysplasia","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D002578","descriptor_name":"Uterine Cervical Dysplasia","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D002583","descriptor_name":"Uterine Cervical Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002583","descriptor_name":"Uterine Cervical Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D002583","descriptor_name":"Uterine Cervical Neoplasms","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005838","descriptor_name":"Genotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D027383","descriptor_name":"Papillomaviridae","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D030361","descriptor_name":"Papillomavirus Infections","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D030361","descriptor_name":"Papillomavirus Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":true},{"descriptor_ui":"D053918","descriptor_name":"Papillomavirus Vaccines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D053918","descriptor_name":"Papillomavirus Vaccines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.ygyno.2019.03.250","doi":"https://doi.org/10.1016/j.ygyno.2019.03.250","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ygyno.2019.03.250","pdf_url":"http://www.gynecologiconcology-online.net/article/S0090825819304846/pdf","source":{"id":"https://openalex.org/S2574783","display_name":"Gynecologic Oncology","issn_l":"0090-8258","issn":["0090-8258","1095-6859"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gynecologic Oncology","raw_type":"journal-article"},{"id":"pmid:30955915","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30955915","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gynecologic oncology","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:helda.helsinki.fi:10138/307221","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10138/307221","pdf_url":null,"source":{"id":"https://openalex.org/S4210213322","display_name":"Ty\u00f6v\u00e4entutkimus Vuosikirja","issn_l":"0784-1272","issn":["0784-1272","1459-7780"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["ddh","jufo-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1016/j.ygyno.2019.03.250","doi":"https://doi.org/10.1016/j.ygyno.2019.03.250","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ygyno.2019.03.250","pdf_url":"http://www.gynecologiconcology-online.net/article/S0090825819304846/pdf","source":{"id":"https://openalex.org/S2574783","display_name":"Gynecologic Oncology","issn_l":"0090-8258","issn":["0090-8258","1095-6859"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gynecologic Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307779","display_name":"Roche","ror":"https://ror.org/00by1q217"},{"id":"https://openalex.org/F4320309432","display_name":"F. Hoffmann-La Roche","ror":"https://ror.org/00by1q217"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2931635538.pdf","grobid_xml":"https://content.openalex.org/works/W2931635538.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W1688526230","https://openalex.org/W1796023353","https://openalex.org/W1969397804","https://openalex.org/W1975739500","https://openalex.org/W1984554440","https://openalex.org/W1986176394","https://openalex.org/W2023040927","https://openalex.org/W2027219091","https://openalex.org/W2051562719","https://openalex.org/W2068487799","https://openalex.org/W2072801696","https://openalex.org/W2109715542","https://openalex.org/W2129727233","https://openalex.org/W2147653557","https://openalex.org/W2175844702","https://openalex.org/W2176203755","https://openalex.org/W2179671231","https://openalex.org/W2472221349","https://openalex.org/W2489063059","https://openalex.org/W2552084629","https://openalex.org/W2556396064","https://openalex.org/W2606020258","https://openalex.org/W2765170027","https://openalex.org/W2767266730","https://openalex.org/W2889646458"],"related_works":["https://openalex.org/W2937656653","https://openalex.org/W4231422336","https://openalex.org/W4387940628","https://openalex.org/W2946772397","https://openalex.org/W4296758128","https://openalex.org/W3011979767","https://openalex.org/W2209603642","https://openalex.org/W3164538268","https://openalex.org/W2747684038","https://openalex.org/W2113960129"],"abstract_inverted_index":{"BACKGROUND:":[0],"While":[1],"prophylactic":[2],"human":[3],"papillomavirus":[4],"(HPV)":[5],"vaccination":[6],"exists,":[7],"women":[8,135],"are":[9],"still":[10],"developing":[11],"cervical":[12],"intraepithelial":[13],"neoplasia":[14],"(CIN)":[15],"grade":[16],"2":[17],"or":[18],"3":[19,177],"for":[20,154,174],"which":[21],"an":[22],"immunotherapeutic,":[23],"non-surgical,":[24],"approach":[25],"may":[26],"be":[27],"effective.":[28],"The":[29,85,116,210,226],"primary":[30,86],"aim":[31],"was":[32,96,145,198,212],"to":[33,78,137,141,205],"assess":[34],"the":[35,93,133,149,159,201,216],"efficacy":[36],"of":[37,46,128,158,180,191,232,236,243],"tipapkinogen":[38],"sovacivec":[39],"(TS)":[40],"vaccine":[41,138,150,202,211,228],"in":[42,67,80,148,200,240],"achieving":[43],"histologic":[44,230],"resolution":[45,144],"CIN2/3":[47,64],"associated":[48],"with":[49,215],"high":[50],"risk":[51],"(HR)":[52],"HPV":[53,101,162,182,193,238],"types.":[54],"METHODS:":[55],"Women":[56],"18":[57],"years":[58],"and":[59,76,99,109,139,245],"older":[60],"who":[61,122],"had":[62],"confirmed":[63],"were":[65,103],"enrolled":[66],"a":[68,81],"randomized,":[69],"double":[70],"blind,":[71],"placebo-controlled":[72],"phase":[73],"II":[74],"trial":[75],"assigned":[77],"drug":[79],"2:1":[82],"ratio":[83],"(vaccine:placebo).":[84],"endpoint":[87],"occurred":[88],"at":[89,105,124],"month":[90,114],"6":[91,108],"when":[92],"excisional":[94],"therapy":[95],"performed;":[97],"cytology":[98],"HR":[100,161,181,237],"typing":[102],"performed":[104],"months":[106,112],"3,":[107],"every":[110],"six":[111],"through":[113,249],"30.":[115],"safety":[117],"population":[118],"included":[119],"all":[120],"patients":[121],"received":[123],"least":[125],"one":[126,241],"dose":[127],"study":[129],"drug.":[130],"RESULTS:":[131],"Of":[132],"129":[134],"randomized":[136],"63":[140],"placebo,":[142],"complete":[143],"significantly":[146],"higher":[147,199],"group":[151,203],"than":[152],"placebo":[153,206],"CIN":[155,176,233],"2/3":[156,234],"regardless":[157,179],"13":[160],"types":[163],"assayed":[164],"(24%":[165],"vs.":[166,185],"10%,":[167],"p":[168,187],"<":[169,188,208],"0.05);":[170],"as":[171,173],"well":[172,213],"only":[175],"also":[178],"type":[183,239],"(21%":[184],"0%,":[186],"0.01).":[189,209],"Irrespective":[190],"baseline":[192],"infection,":[194],"viral":[195],"DNA":[196],"clearance":[197,231],"compared":[204],"(p":[207],"tolerated":[214],"most":[217],"common":[218],"adverse":[219],"events":[220],"being":[221],"injection":[222],"site":[223],"reactions.":[224],"CONCLUSIONS:":[225],"TS":[227],"provides":[229],"irrespective":[235],"third":[242],"subjects":[244],"is":[246],"generally":[247],"safe":[248],"30":[250],"months.":[251]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":17},{"year":2023,"cited_by_count":14},{"year":2022,"cited_by_count":15},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2019-04-11T00:00:00"}